Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Grains Research and Development Corporation (GRDC) invests over $198 million annually in around 780 research, development, and extension projects to deliver new crop varieties, improved farming practices, technologies, and capabilities for the Australian grains industry. It aims to drive innovation that enhances productivity, profitability, sustainability for grain growers across Australia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grains Research and Development Corporation.